Your privacy is important to us. Cookies are very small text files that are stored on your computer when you visit a website. We use cookies and other tracking technologies for a variety of purposes and to enhance your online experience on our website. You can change your preferences and decline certain types of cookies to be stored on your computer while browsing our website. You can also remove any cookies already stored on your computer, but keep in mind that deleting cookies may prevent you from using parts of our website. You can check our privacy policy page for more information.
-
press releaseWASHINGTON, D.C. (May 1, 2023) –Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) filed an amicus brief alongside other leading industry stakeholders in the U.S. Court of Appeals for the Fifth Circuit in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration (FDA).
“It is wrong for any court to replace the FDA’s expert scientific decision embodied in a drug approval with its own judgment. The FDA is authorized by Congress to evaluate the safety and efficacy of medicines – and the Agency is the gold standard for regulatory review. The district court’s ruling would upend the successful regulatory framework on which biopharmaceutical research and development depends,” said PhRMA Executive Vice President, General Counsel and Corporate Secretary Jim Stansel.
The brief largely focuses on two central arguments:
For the complete filing, please see here.
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives. Since 2000, PhRMA member companies have invested more than $1.1 trillion in the search for new treatments and cures, including $102.3 billion in 2021 alone.
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.MAT.org
www.Facebook.com/PhRMA
www.Twitter.com/PhRMA
This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.